Literature DB >> 9056581

Individual bioequivalence--a regulatory update.

M L Chen1.   

Abstract

Mesh：

Year:  1997        PMID： 9056581     DOI： 10.1080/10543409708835162

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN： 1054-3406            Impact factor:   1.051


× No keyword cloud information.
  6 in total

Review 1.  Individual bioequivalence revisited.

Authors:  M L Chen; L J Lesko
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Subject-by-formulation interaction in determinations of individual bioequivalence: bias and prevalence.

Authors:  L Endrenyi; L Tothfalusi
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

3.  Statistical aspects of bioequivalence testing between two medicinal products.

Authors:  E Zintzaras
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

Review 4.  Requirements for generic antiepileptic medicines: a clinical perspective.

Authors:  Eugen Trinka; Günter Krämer; Martin Graf
Journal:  J Neurol       Date:  2011-06-11       Impact factor: 4.849

5.  Management of narrow therapeutic index drugs.

Authors:  M Burns
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

6.  Assessing individual equivalence in parallel group and crossover designs: Exact test and sample size procedures.

Authors:  Gwowen Shieh
Journal:  PLoS One       Date:  2022-05-27       Impact factor: 3.752
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.